NLRP3 Inflammasome May Be a Biomarker for Risk Stratification in Patients with Acute Coronary Syndrome

PURPOSE: Acute coronary syndrome (ACS) has a high incidence and mortality rate worldwide, which has a considerable negative impact on the global economy. This study aimed to identify a group of ACS patients at a high risk of recurrent adverse cardiac events using the plasma NLRP3 inflammasome. PATIE...

Descripción completa

Detalles Bibliográficos
Autores principales: Mo, De-Gang, Wang, Lin, Han, Qian-Feng, Yu, Kang, Liu, Jia-Hui, Yao, Heng-Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739063/
https://www.ncbi.nlm.nih.gov/pubmed/36510493
http://dx.doi.org/10.2147/JIR.S383903

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739063/
https://www.ncbi.nlm.nih.gov/pubmed/36510493
http://dx.doi.org/10.2147/JIR.S383903

Ejemplares similares